Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Invested Capital (2016 - 2025)

Biomerica's Invested Capital history spans 15 years, with the latest figure at $4.4 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 13.28% year-over-year to $4.4 million; the TTM value through Nov 2025 reached $4.4 million, down 13.28%, while the annual FY2025 figure was $4.1 million, 37.72% down from the prior year.
  • Invested Capital for Q4 2025 was $4.4 million at Biomerica, down from $5.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $11.7 million in Q2 2023 and bottomed at $4.1 million in Q2 2025.
  • The 5-year median for Invested Capital is $8.1 million (2022), against an average of $7.7 million.
  • The largest annual shift saw Invested Capital surged 126.44% in 2021 before it plummeted 50.35% in 2024.
  • A 5-year view of Invested Capital shows it stood at $8.9 million in 2021, then decreased by 18.62% to $7.2 million in 2022, then increased by 29.53% to $9.4 million in 2023, then crashed by 45.5% to $5.1 million in 2024, then fell by 13.28% to $4.4 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Invested Capital are $4.4 million (Q4 2025), $5.2 million (Q3 2025), and $4.1 million (Q2 2025).